AfrECC is a worldwide network of researchers, clinicians, and trainees working to prevent, detect, and treat esophageal cancer across eastern and southern Africa.
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest and most neglected cancers in the world. In eastern and southern Africa, the burden is exceptionally high and the resources to address it are severely limited.
New cases diagnosed in Africa annually.
Median survival after diagnosis in the African Corridor.
Deaths recorded globally each year due to esophageal cancer.
Of patients are under 45, even non-smokers and non-drinkers.
The African Esophageal Cancer Consortium (AfrECC) was formed in 2016 following a meeting at the National Cancer Institute that highlighted the exceptional burden of ESCC in Africa. Today, the consortium spans 15 sites across 11 countries, uniting over 100 researchers, clinicians, and trainees around a shared mission.
In 2024, the AfrECC Foundation was established to provide dedicated financial support for the consortium's work.
From laboratory research to bedside care, AfrECC takes an integrated approach to reducing the burden of esophageal cancer across Africa.
Investigating the environmental, lifestyle, and genetic causes of ESCC.
Developing and testing screening tools to catch the disease at earlier stages.
Building local expertise through hands-on endoscopy workshops across Africa.
Expanding access to esophageal stents to restore swallowing and improve quality of life.
Engaging governments to prioritize ESCC in national cancer control plans.